StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.61+0.02 (+3.06%)

Close on Nov 17, 2026Market cap $3.44MP/E –Yield –

Imunon total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Imunon's total debt was $4.61M at Dec 31, 2022. For fiscal 2022 it was $4.61M, down 21.2% from the year before. Over ten years it grew 55.3% a year on average. The highest annual figure on record is $9.42M in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$4.61M-21.2%
FY2021Dec 31, 2021$5.85M+48.8%
FY2020Dec 31, 2020$3.93M-50.6%
FY2019Dec 31, 2019$7.96M-15.4%
FY2018Dec 31, 2018$9.42M+300.7%
FY2015Dec 31, 2015$2.35M-61.2%
FY2014Dec 31, 2014$6.05M+21.1%
FY2013Dec 31, 2013$5.00M+36.6%
FY2012Dec 31, 2012$3.66M+5013.2%
FY2011Dec 31, 2011$71.60K+26.9%
FY2010Dec 31, 2010$56.40K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$4.61M-21.2%
Q3 FY2022Sep 30, 2022$5.32M-8.4%
Q2 FY2022Jun 30, 2022$5.95M+3.2%
Q1 FY2022Mar 31, 2022$5.90M+81.4%
Q4 FY2021Dec 31, 2021$5.85M+48.8%
Q3 FY2021Sep 30, 2021$5.81M+25.5%
Q2 FY2021Jun 30, 2021$5.76M+2.7%
Q1 FY2021Mar 31, 2021$3.25M-57.3%
Q4 FY2020Dec 31, 2020$3.93M-50.6%
Q3 FY2020Sep 30, 2020$4.63M-49.3%
Q2 FY2020Jun 30, 2020$5.61M-41.6%
Q1 FY2020Mar 31, 2020$7.62M-19.9%
Q4 FY2019Dec 31, 2019$7.96M-15.4%
Q3 FY2019Sep 30, 2019$9.13M-2.1%
Q2 FY2019Jun 30, 2019$9.61M+4.2%
Q1 FY2019Mar 31, 2019$9.51M+621.1%
Q4 FY2018Dec 31, 2018$9.42M–
Q3 FY2018Sep 30, 2018$9.32M–
Q2 FY2018Jun 30, 2018$9.22M–
Q1 FY2016Mar 31, 2016$1.32M–

More Imunon figures

See a number that looks wrong?